232) ferent methods of connecting primary care patients with community-based physical act |
233) sing attention is connecting primary care patients with community-based physical act |
234) Elderly and patients with comorbidities and organ fail |
235) r hand, identifying ACE2 dysregulation in patients with comorbidities may offer insi |
236) Diet therapy is an option for managing patients with drug-resistant epilepsy (DRE |
237) Thirty patients with drug-resistant focal epileps |
238) icantly decreased in cardiac samples from patients with heart failure with reduced e |
239) e decisions are common and challenging to patients with heart failure. |
240) e risk of spinal and epidural hematoma in patients with hemorrhagic disorders and te |
241) on and removal of neuraxial anesthesia in patients with hemorrhagic disorders and te |
242) SLE patients with high disease activity had in |
243) on rate in response to DIP adoption among patients with high severity. |
244) One hundred fifty patients with high-risk hematological mali |
245) itabine plus oxaliplatin for 3 months in patients with high-risk stage II or low-ri |
246) nd alternative sequences are mandatory in patients with known SLE who present with a |
247) riables influencing ICU use, for COVID-19 patients with known cardiovascular disease |
248) icant factor for the treatment outcome in patients with locally advanced non-small-c |
249) ses in an attempt to improve outcomes for patients with locally advanced renal cell |
250) bulin was previously tested in unselected patients with lung cancer and yielded a mo |
251) e mutations as a biomarker of response in patients with lung cancer. |
252) tor approved for the treatment of certain patients with mIDH1 acute myeloid leukemia |
253) sidenib and are consistent with data from patients with mIDH1 cancers and healthy pa |
254) the pathophysiology of memory deficits in patients with major depressive disorder (M |
255) ons related to medication adherence among patients with major depressive disorder (M |
256) 35 patients with metastatic TNBC were recruit |
257) P4HA2 is significantly upregulated in UM patients with metastatic disease and corre |
258) ue that was 9.6-fold higher than that for patients with mild disease and 5.0-fold hi |
259) 41.9% for patients with mild or moderate illness and |
260) Patients with neurologic or ophthalmic dis |
261) Similarly, patients with neurologic disease experienc |
262) devices used in music-based therapies in patients with neurological disorders: 46 s |
263) the assessment of cognitive functions in patients with neurological or psychiatric |
264) However, patients with no genetically predisposing |
add keyword